Company intelligence / Profile preview
OROX BioSciences
San Diego, California, United Statesoroxbios.com ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
OROX BioSciences is an early-stage biotech startup developing small molecule inhibitors of sEH for oncology and fibrosis indications. There are no reported clinical trial results as of the latest available information; programs appear to be in the discovery or preclinical validation stage[1][5].
- Therapeutic areas
- OncologyPulmonologyOther
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on OROX BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OROX BioSciences.